HeartFlow announces merger with Longview Acquisition Corp. II to become publicly traded company

On July 15, 2021, HeartFlow and Longview Acquisition Corp. II, a special purpose acquisition company sponsored by Glenview Capital Management, LLC, have entered into a definitive business combination agreement that will support HeartFlow’s vision of revolutionizing precision heartcare.

Learn more: https://bit.ly/3rbbkvm